StonvexLoading…
StonvexStonvexStonvexCore line items from SBAC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $721.21M | $47.29M | $244.50M | $191.13M | $115.23M |
Operating Income | Not available | $342.85M | $1.34B | $374.17M | $334.78M |
Net Income | Not available | $184.83M | $1.05B | $236.82M | $225.79M |
EPS (Diluted) | $1.92 | $1.74 | $9.80 | $2.20 | $2.09 |
Total Assets | Not available | $11.72B | $11.58B | $11.26B | $10.77B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $269.06M | $264.57M | $430.31M | $275.27M |
Free Cash Flow OCF − CapEx | Not available | $206.69M | $1.07B | $825.21M | $567.24M |
Shares Outstanding | Not available | 106.06M | 105.67M | 106.77M | 107.49M |